Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Geert Verbeke

Showing results (141-150 of 144) with videos related to

Pageof 15
Sort By:
You have reached the last page of results.This site can display upto 144 results.
Trials|November 28, 2020
A randomized, multicentre, open-label phase II proof-of-concept trial investigating the clinical efficacy and safety of the addition of convalescent plasma to the standard of care in patients hospitalized with COVID-19: the Donated Antibodies Working against nCoV (DAWn-Plasma) trialTimothy Devos, Tatjana Geukens, Alexander Schauwvlieghe, et al.
Trials|December 15, 2020
Correction to: A randomized, multicentre, open-label phase II proof-of-concept trial investigating the clinical efficacy and safety of the addition of convalescent plasma to the standard of care in patients hospitalized with COVID-19: the Donated Antibodies Working against nCoV (DAWn-Plasma) trialTimothy Devos, Tatjana Geukens, Alexander Schauwvlieghe, et al.
Ebiomedicine|March 22, 2021
Itraconazole for COVID-19: preclinical studies and a proof-of-concept randomized clinical trialLaurens Liesenborghs, Isabel Spriet, Dirk Jochmans, et al.
Ebiomedicine|June 29, 2021
Corrigendum to "itraconazole for COVID-19: Preclinical studies and a proof-of-concept randomized clinical trial Laurens"Laurens Liesenborghs, Isabel Spriet, Dirk Jochmans, et al.
Pageof 15

Showing results (141-150 of 144) with videos related to

Sort By:
Pageof 15
You have reached the last page of results.This site can display upto 144 results.
Trials|November 28, 2020
A randomized, multicentre, open-label phase II proof-of-concept trial investigating the clinical efficacy and safety of the addition of convalescent plasma to the standard of care in patients hospitalized with COVID-19: the Donated Antibodies Working against nCoV (DAWn-Plasma) trialTimothy Devos, Tatjana Geukens, Alexander Schauwvlieghe, et al.
Trials|December 15, 2020
Correction to: A randomized, multicentre, open-label phase II proof-of-concept trial investigating the clinical efficacy and safety of the addition of convalescent plasma to the standard of care in patients hospitalized with COVID-19: the Donated Antibodies Working against nCoV (DAWn-Plasma) trialTimothy Devos, Tatjana Geukens, Alexander Schauwvlieghe, et al.
Ebiomedicine|March 22, 2021
Itraconazole for COVID-19: preclinical studies and a proof-of-concept randomized clinical trialLaurens Liesenborghs, Isabel Spriet, Dirk Jochmans, et al.
Ebiomedicine|June 29, 2021
Corrigendum to "itraconazole for COVID-19: Preclinical studies and a proof-of-concept randomized clinical trial Laurens"Laurens Liesenborghs, Isabel Spriet, Dirk Jochmans, et al.
Pageof 15